4//SEC Filing
Shukla Sanjay 4
Accession 0000950170-25-013891
CIK 0001339970other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:18 PM ET
Size
7.1 KB
Accession
0000950170-25-013891
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-03+10,375→ 146,923 total - Exercise/Conversion
Restricted Stock Unit
2025-02-03−10,375→ 10,375 total→ Common Stock (10,375 underlying)
Footnotes (3)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:18 PM ET
- Size
- 7.1 KB